首页 › 基金 › Birchview Capital, LP › VALN
Birchview Capital, LP 对 VALN 的持仓历史
VALNEVA SE · 医疗保健
Birchview Capital, LP 在 Q3 2026 的 13F 申报中披露持有 VALN(VALNEVA SE)201,390 股,市值约 US$1.2M,约占其申报组合的 0.74%,在其申报持仓中市值排名第 34 位。 Birchview Capital, LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Birchview Capital, LP 对 VALN 的持仓演变
Birchview Capital, LP 于 Q3 2026 首次披露 VALN 持仓:201,390 股(约 US$1.2M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 201.39K | $1.25M | 新进 |
关于 VALN 与 13F 数据
VALN(VALNEVA SE)属于医疗保健行业。我们追踪的基金中还有 25 只申报持有 VALN,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$12.0M), Vivo Capital, LLC (US$4.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VALN 的基金
- Frazier Life Sciences Management, L.P. 2.29M 股 · $11.99M · Q2 2026
- Vivo Capital, LLC 763.20K 股 · $4.72M · Q3 2026
更多关于 Birchview Capital, LP
常见问题
How long has Birchview Capital, LP held VALN?
Birchview Capital, LP has disclosed VALN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Birchview Capital, LP's current position in VALN?
As of Q3 2026, Birchview Capital, LP holds 201.39K shares of VALN (VALNEVA SE), valued at $1.25M, representing 0.74% of its reported portfolio and ranking #34.
Has Birchview Capital, LP been buying or selling VALN?
In the latest 13F filing (Q3 2026), Birchview Capital, LP newly opened its position in VALN.
Which other funds hold VALN?
Other major institutional holders of VALN include Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.